During the past decade, Visionary Investigators Network conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 4 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 4 clinical trials were completed. i.e. 26.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Visionary Investigators Network" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Allergan" with 2 trials sponsored, "Impax Laboratories, LLC" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Visionary Investigators Network" #1 collaborator was "Alzheimer's Association" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Clinilabs, Inc." with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator and "Novotech Health Holdings Pte. Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Visionary Investigators Network" are "Alzheimer Disease" (6 trials), "Gastroparesis" (2 trials), "Migraine" (2 trials), "Mild Cognitive Impairment" (2 trials) and "Parkinson Disease" (2 trials). Many other conditions were trialed in "Visionary Investigators Network" in a lesser frequency.

Most popular intervention types in "Visionary Investigators Network" are "Drug" (21 trials), "Other" (4 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "placebo" (2 trials), "15mg T3D-959" (1 trials), "30 mg T3D-959" (1 trials) and "45 mg T3D-959" (1 trials). Other intervention names were less common.

The vast majority of trials in "Visionary Investigators Network" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Visionary Investigators Network". undefined are not yet recruiting, 5 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Visionary Investigators Network, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Visionary Investigators Network, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".